BRAF and metastatic melanoma: Patients with BRAFV600E mutant metastatic melanoma were also associated with a significantly younger age (median= 57.0 years) compared to patients with BRAF wild-type melanoma (median= 67.0, P= 2.5 × 10−7, Mann-Whitney test).